Congratulations to CE Approval for Safecare COVID-19 & Influenza A+B

On April 29, 2022, by Safecare Biotech (Hangzhou) Co., Ltd. has successfully obtained the Notified Body CE certificate for Safecare COVID-19 & Influenza A+B Antigen Combo Rapid Test( Self-testing), who is the first company in China. This means our Safecare COVID-19 & Influenza A+B Antigen Combo Rapid Test( Self-testing) can be used at home in European markets and all the markets that accept CE approval.

We Safecare are always working very hard on the new products and committed to make contributions to defeating the epidemic.